Treatment of chronic hepatitis D with peginterferon lambda-the phase 2 LIMT-1 clinical trial.

Ohad Etzion,Saeed Hamid,Yoav Lurie,Edward J Gane,David Yardeni,Sarah Duehren,Nimrah Bader,Anat Nevo-Shor,Saleh Muhammad Channa,Scott J Cotler,Minaz Mawani,Om Parkash,Harel Dahari,Ingrid Choong,Jeffrey S Glenn

Hepatology (Baltimore, Md.)（2023）

引用 2|浏览30

暂无评分

摘要

Treatment with Lambda in patients with chronic HDV may result in virologic response during and following treatment cessation. Clinical phase 3 development of Lambda for this rare and serious disease is ongoing.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要